Turnstone Biologics Corp. Quarterly Return On Equity in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Turnstone Biologics Corp. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q2 2024.
  • Turnstone Biologics Corp. Return On Equity for the quarter ending June 30, 2024 was -84.8 %, a 271% decline year-over-year.
  • Turnstone Biologics Corp. annual Return On Equity for 2023 was 2.67K %, a 7704% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -84.8 -135 -271% Apr 1, 2024 Jun 30, 2024
Q1 2024 -174 -194 -980% Jan 1, 2024 Mar 31, 2024
Q4 2023 2.67K +2.64K +7704% Oct 1, 2023 Dec 31, 2023
Q3 2023 101 Jul 1, 2023 Sep 30, 2023
Q2 2023 49.7 Apr 1, 2023 Jun 30, 2023
Q1 2023 19.8 Jan 1, 2023 Mar 31, 2023
Q4 2022 34.3 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.